These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12775275)

  • 1. Telomerase activity in diagnosis of bladder cancer.
    Erdem E; Dikmen G; Atsü N; Dogan P; Ozen H
    Scand J Urol Nephrol; 2003; 37(3):205-9. PubMed ID: 12775275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine.
    Yoshida K; Sugino T; Tahara H; Woodman A; Bolodeoku J; Nargund V; Fellows G; Goodison S; Tahara E; Tarin D
    Cancer; 1997 Jan; 79(2):362-9. PubMed ID: 9010110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
    Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
    Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
    Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
    J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
    Rahat MA; Lahat N; Gazawi H; Resnick MB; Sova Y; Ben-Ari G; Cohen M; Stein A
    Cancer; 1999 Feb; 85(4):919-24. PubMed ID: 10091771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
    Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
    Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
    Kavaler E; Landman J; Chang Y; Droller MJ; Liu BC
    Cancer; 1998 Feb; 82(4):708-14. PubMed ID: 9477104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
    Yokota K; Kanda K; Inoue Y; Kanayama H; Kagawa S
    Br J Urol; 1998 Nov; 82(5):727-32. PubMed ID: 9839590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.
    Yang SC; Lee DH; Hong SJ; Chung BH; Kim IY
    Yonsei Med J; 1997 Jun; 38(3):155-9. PubMed ID: 9259615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity in solid transitional cell carcinoma, bladder washings, and voided urine.
    Lance RS; Aldous WK; Blaser J; Thrasher JB
    Urol Oncol; 1998 Mar; 4(2):43-9. PubMed ID: 21227190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
    Eissa S; Labib RA; Mourad MS; Kamel K; El-Ahmady O
    Eur Urol; 2003 Dec; 44(6):687-94. PubMed ID: 14644121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of urinary molecular markers in bladder cancer.
    Eissa S; Swellam M; el-Mosallamy H; Mourad MS; Hamdy NΜ; Kamel K; Zaglol AS; Khafagy MM; el-Ahmady O
    Anticancer Res; 2003; 23(5b):4347-55. PubMed ID: 14666650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in human urothelial tumors.
    Kyo S; Kunimi K; Uchibayashi T; Namiki M; Inoue M
    Am J Clin Pathol; 1997 May; 107(5):555-60. PubMed ID: 9128268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of bladder cancer using telomerase activity in voided urine.
    Cheng CW; Chueh SC; Chern HD
    J Formos Med Assoc; 2000 Dec; 99(12):920-5. PubMed ID: 11155745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
    Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
    Cassel A; Rahat MA; Lahat N; Lindenfeld N; Mecz Y; Stein A
    J Urol; 2001 Sep; 166(3):841-4. PubMed ID: 11490230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
    Heine B; Hummel M; Müller M; Heicappell R; Miller K; Stein H
    J Pathol; 1998 Jan; 184(1):71-6. PubMed ID: 9582530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
    Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
    J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.